High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv

被引：238

作者：

Ananthan, Subramaniam ^{[1
]}

Faaleolea, Ellen R. ^{[2
]}

Goldman, Robert C. ^{[3
]}

Hobrath, Judith V. ^{[1
]}

Kwong, Cecil D. ^{[1
]}

Laughon, Barbara E. ^{[3
]}

Maddry, Joseph A. ^{[1
]}

Mehta, Alka ^{[1
]}

Rasmussen, Lynn ^{[1
]}

Reynolds, Robert C. ^{[1
]}

Secrist, John A., III ^{[1
]}

Shindo, Nice ^{[1
]}

Showe, Dustin N. ^{[2
]}

Sosa, Melinda I. ^{[1
]}

Suling, William J. ^{[1
]}

White, E. Lucile ^{[1
]}

机构：

[1] So Res Inst, Birmingham, AL 35205 USA

[2] So Res Inst, Frederick, MD 21701 USA

[3] NIAID, DHHS, NIH,Therapeut Res Program,Complicat & Coinfect Br, Div Acquired Immunodeficiency Syndrome, Bethesda, MD USA

来源：

TUBERCULOSIS | 2009年 / 89卷 / 05期

关键词：

TAACF; Antitubercular; High-throughput screening methods; Medicinal chemistry analysis; Medicinally relevant chemical library; DRUG-RESISTANT TUBERCULOSIS; RING-SUBSTITUTED QUINOLINES; MEFLOQUINE-BASED LIGANDS; CELL-WALL BIOSYNTHESIS; PLATE-BASED SCREEN; MULTIDRUG-RESISTANT; IN-VITRO; ANTIMYCOBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; BIOLOGICAL EVALUATION;

D O I：

10.1016/j.tube.2009.05.008

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

There is an urgent need for the discovery and development of new antitubercular agents that target new biochemical pathways and treat drug resistant forms of the disease. One approach to addressing this need is through high-throughput screening of medicinally relevant libraries against the whole bacterium in order to discover a variety of new, active scaffolds that will stimulate new biological research and drug discovery. Through the Tuberculosis Antimicrobial Acquisition and Coordinating Facility (www.taacf.org), a large, medicinally relevant chemical library was screened against M. tuberculosis strain H37Rv. The screening methods and a medicinal chemistry analysis of the results are reported herein. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：334 / 353

页数：20

共 138 条

[1] BIOLOGICALLY-ACTIVE POLYCYCLOALKANES .1. ANTIVIRAL ADAMANTANE DERIVATIVES
AIGAMI, K
INAMOTO, Y
TAKAISHI, N
HATTORI, K
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1975, 18 (07) : 713 - 721
[2] Synthesis, analgesic, anti-inflammatory and antibacterial activities of some novel 2-butyl-3-substituted quinazolin-4-(3H)-ones
Alagarsamy, V
Rajasolomon, V
Meena, R
Ramseshu, KV
[J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (06) : 1091 - 1094
[3] ALBERT A, 1985, SELECTIVE TOXICITY P, P469
[4] Characterization of the Mycobacterium tuberculosis iniBAC promoter, a promoter that responds to cell wall biosynthesis inhibition
Alland, D
Steyn, AJ
Weisbrod, T
Aldrich, K
Jacobs, WR
[J]. JOURNAL OF BACTERIOLOGY, 2000, 182 (07) : 1802 - 1811
[5] Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy
Alonso, Sylvie
Pethe, Kevin
Russell, David G.
Purdy, Georgiana E.
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (14) : 6031 - 6036
[6] Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma
Amaravadi, Ravi K.
Yu, Duonan
Lum, Julian J.
Bui, Thi
Christophorou, Maria A.
Evan, Gerard I.
Thomas-Tikhonenko, Andrei
Thompson, Craig B.
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (02) : 326 - 336
[7] The eukaryotic-like Ser/Thr protein kinases of Mycobacterium tuberculosis
Av-Gay, Y
Everett, M
[J]. TRENDS IN MICROBIOLOGY, 2000, 8 (05) : 238 - 244
[8] Extensively drug-resistant tuberculosis in California, 1993-2006
Banerjee, Ritu
Allen, Jennifer
Westenhouse, Janice
Oh, Peter
Elms, William
Desmond, Ed
Nitta, Annette
Royce, Sarah
Flood, Jennifer
[J]. CLINICAL INFECTIOUS DISEASES, 2008, 47 (04) : 450 - 457
[9] Activity of 7-methyljuglone in combination with antituberculous drugs against Mycobacterium tuberculosis
Bapela, N. B.
Lall, N.
Fourie, P. B.
Franzblau, S. G.
Van Rensburg, C. E. J.
[J]. PHYTOMEDICINE, 2006, 13 (9-10) : 630 - 635
[10] Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs
Barry, CE
Slayden, RA
Sampson, AE
Lee, RE
[J]. BIOCHEMICAL PHARMACOLOGY, 2000, 59 (03) : 221 - 231

← 1 2 3 4 5 6 7 8 9 10 →